127 related articles for article (PubMed ID: 36993422)
1. GD2 and its biosynthetic enzyme GD3 synthase promote tumorigenesis in prostate cancer by regulating cancer stem cell behavior.
Bhat AM; Mohapatra BC; Luan H; Mushtaq I; Chakraborty S; Kumar S; Wu W; Nolan B; Dutta S; Stock MD; Schott M; Meza JL; Lele SM; Lin MF; Cook LM; Corey E; Morrissey C; Coulter DW; Rowley J; Natarajan A; Datta K; Band V; Band H
bioRxiv; 2024 Apr; ():. PubMed ID: 36993422
[TBL] [Abstract][Full Text] [Related]
2. GD2 and its biosynthetic enzyme GD3 synthase promote tumorigenesis in prostate cancer by regulating cancer stem cell behavior.
Bhat AM; Mohapatra BC; Luan H; Mushtaq I; Chakraborty S; Kumar S; Wu W; Nolan B; Dutta S; Storck MD; Schott M; Meza JL; Lele SM; Lin MF; Cook LM; Corey E; Morrissey C; Coulter DW; Rowley MJ; Natarajan A; Datta K; Band V; Band H
Sci Rep; 2024 Jun; 14(1):13523. PubMed ID: 38866755
[TBL] [Abstract][Full Text] [Related]
3. Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis.
Battula VL; Shi Y; Evans KW; Wang RY; Spaeth EL; Jacamo RO; Guerra R; Sahin AA; Marini FC; Hortobagyi G; Mani SA; Andreeff M
J Clin Invest; 2012 Jun; 122(6):2066-78. PubMed ID: 22585577
[TBL] [Abstract][Full Text] [Related]
4. Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype.
Liang YJ; Wang CY; Wang IA; Chen YW; Li LT; Lin CY; Ho MY; Chou TL; Wang YH; Chiou SP; Lin YJ; Yu J
Oncotarget; 2017 Jul; 8(29):47454-47473. PubMed ID: 28537895
[TBL] [Abstract][Full Text] [Related]
5. GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancer.
Sarkar TR; Battula VL; Werden SJ; Vijay GV; Ramirez-Peña EQ; Taube JH; Chang JT; Miura N; Porter W; Sphyris N; Andreeff M; Mani SA
Oncogene; 2015 Jun; 34(23):2958-67. PubMed ID: 25109336
[TBL] [Abstract][Full Text] [Related]
6. Disialyl GD2 ganglioside suppresses ICAM-1-mediated invasiveness in human breast cancer MDA-MB231 cells.
Kwon KM; Chung TW; Kwak CH; Choi HJ; Kim KW; Ha SH; Cho SH; Lee YC; Ha KT; Lee MJ; Kim CH
Int J Biol Sci; 2017; 13(3):265-275. PubMed ID: 28367091
[TBL] [Abstract][Full Text] [Related]
7. Ganglioside GD3 synthase (GD3S), a novel cancer drug target.
Liu J; Zheng X; Pang X; Li L; Wang J; Yang C; Du G
Acta Pharm Sin B; 2018 Sep; 8(5):713-720. PubMed ID: 30245960
[TBL] [Abstract][Full Text] [Related]
8. IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells.
Battula VL; Nguyen K; Sun J; Pitner MK; Yuan B; Bartholomeusz C; Hail N; Andreeff M
Oncotarget; 2017 Jun; 8(23):36936-36949. PubMed ID: 28415808
[TBL] [Abstract][Full Text] [Related]
9. Glycosphingolipids in human embryonic stem cells and breast cancer stem cells, and potential cancer therapy strategies based on their structures and functions.
Liang YJ
Glycoconj J; 2022 Apr; 39(2):177-195. PubMed ID: 35267131
[TBL] [Abstract][Full Text] [Related]
10. Ganglioside GD2: a novel therapeutic target in triple-negative breast cancer.
Shao C; Anand V; Andreeff M; Battula VL
Ann N Y Acad Sci; 2022 Feb; 1508(1):35-53. PubMed ID: 34596246
[TBL] [Abstract][Full Text] [Related]
11. St8sia1-deficiency in mice alters tumor environments of gliomas, leading to reduced disease severity.
Zhang P; Ohkawa Y; Yamamoto S; Momota H; Kato A; Kaneko K; Natsume A; Farhana Y; Ohmi Y; Okajima T; Bhuiyan RH; Wakabayashi T; Furukawa K; Furukawa K
Nagoya J Med Sci; 2021 Aug; 83(3):535-549. PubMed ID: 34552288
[TBL] [Abstract][Full Text] [Related]
12. GD2 and GD3 synthase: novel drug targets for cancer therapy.
Sphyris N; Sarkar TR; Battula VL; Andreeff M; Mani SA
Mol Cell Oncol; 2015; 2(3):e975068. PubMed ID: 27308452
[TBL] [Abstract][Full Text] [Related]
13. The biological role and immunotherapy of gangliosides and GD3 synthase in cancers.
Cao S; Hu X; Ren S; Wang Y; Shao Y; Wu K; Yang Z; Yang W; He G; Li X
Front Cell Dev Biol; 2023; 11():1076862. PubMed ID: 36824365
[TBL] [Abstract][Full Text] [Related]
14. Role of GD3 Synthase ST8Sia I in Cancers.
Kasprowicz A; Sophie GD; Lagadec C; Delannoy P
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267607
[TBL] [Abstract][Full Text] [Related]
15. Relationship of glycosyltransferases and mRNA levels to ganglioside expression in neuroblastoma and melanoma cells.
Ruan S; Raj BK; Lloyd KO
J Neurochem; 1999 Feb; 72(2):514-21. PubMed ID: 9930722
[TBL] [Abstract][Full Text] [Related]
16. Characterization of expression and prognostic implications of GD2 and GD3 synthase in canine histiocytic sarcoma.
Murphy JD; Axiak-Bechtel S; Milner RJ; Lejeune A; Ossiboff RJ; Gell JC; Shiomitsu K
Vet Immunol Immunopathol; 2023 May; 259():110594. PubMed ID: 37058951
[TBL] [Abstract][Full Text] [Related]
17. Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1.
Mabe NW; Huang M; Dalton GN; Alexe G; Schaefer DA; Geraghty AC; Robichaud AL; Conway AS; Khalid D; Mader MM; Belk JA; Ross KN; Sheffer M; Linde MH; Ly N; Yao W; Rotiroti MC; Smith BAH; Wernig M; Bertozzi CR; Monje M; Mitsiades CS; Majeti R; Satpathy AT; Stegmaier K; Majzner RG
Nat Cancer; 2022 Aug; 3(8):976-993. PubMed ID: 35817829
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2.
Iwasawa T; Zhang P; Ohkawa Y; Momota H; Wakabayashi T; Ohmi Y; Bhuiyan RH; Furukawa K; Furukawa K
Int J Oncol; 2018 Apr; 52(4):1255-1266. PubMed ID: 29436609
[TBL] [Abstract][Full Text] [Related]
19. Kinetic and spatial interrelationships between ganglioside glycosyltransferases and O-acetyltransferase(s) in human melanoma cells.
Sjoberg ER; Varki A
J Biol Chem; 1993 May; 268(14):10185-96. PubMed ID: 8486686
[TBL] [Abstract][Full Text] [Related]
20. Multiple Immunofluorescence Imaging Analysis Reveals Differential Expression of Disialogangliosides GD3 and GD2 in Neuroblastomas.
Nishimaki H; Nakanishi Y; Yagasaki H; Masuda S
Pediatr Dev Pathol; 2022; 25(2):141-154. PubMed ID: 34674560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
